Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment

Leukemia researchers have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.